Sort
39,280 grants matching “leukemia”
Signaling Pathways in MDS
$351,720Kathleen Miho Sakamoto · Stanford University · R01 · FY2019 · DK
MALT1 Targeted Therapy for B-Cell Lymphoma
$351,713Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · CA
Targeting Mitotic Kinases Inhibitors for Cancer Therapy
$351,713E Premkumar Reddy · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · CA
HSC Derived MDSC for the Prevention of GHVD Without Suppressing GvL
$351,713Ping-Ying Pan · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · CA
Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia
$351,713Christopher Y Park · New York University School Of Medicine · R01 · FY2017 · CA
MALT1 Targeted Therapy for B-Cell Lymphoma
$351,713Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R01 · FY2014 · CA
MALT1 Targeted Therapy for B-Cell Lymphoma
$351,713Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · CA
MALT1 Targeted Therapy for B-Cell Lymphoma
$351,713Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · CA
Targeting Mitotic Kinases Inhibitors for Cancer Therapy
$351,713E Premkumar Reddy · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · CA
HSC Derived MDSC for the Prevention of GHVD Without Suppressing GvL
$351,713Ping-Ying Pan · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · CA
CHEK1 and WEE1 Inhibition as Therapeutic Strategies in AML
$351,713Raoul Tibes · New York University School Of Medicine · R01 · FY2018 · CA
Function and targeting of a stable transcription factor complex in leukemia
$351,713Robert G Roeder · Rockefeller University · R01 · FY2015 · CA
HSC Derived MDSC for the Prevention of GHVD Without Suppressing GvL
$351,713Ping-Ying Pan · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · CA
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia
$351,713Iannis Aifantis · New York University School Of Medicine · R01 · FY2009 · CA
Function and targeting of a stable transcription factor complex in leukemia
$351,713Robert G Roeder · Rockefeller University · R01 · FY2011 · CA
Function and targeting of a stable transcription factor complex in leukemia
$351,713Robert G Roeder · Rockefeller University · R01 · FY2012 · CA
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia
$351,713Iannis Aifantis · New York University School Of Medicine · R01 · FY2010 · CA
Targeting Mitotic Kinases Inhibitors for Cancer Therapy
$351,713E Premkumar Reddy · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · CA
Development of AMPK Inhibitors for the treatment of leukemia
$351,706Philip Reigan · University Of Colorado Denver · R01 · FY2025 · CA
THE ROLE OF TELOMERASE REGULATORS IN TELOMERE MAINTENANCE AND GENOMIC INSTABILITY
$351,691Zhou Songyang · Baylor College Of Medicine · R01 · FY2019 · CA
Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy
$351,691Alexandru Almasan Almasan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · CA
Cytokine Regulation of Photoreceptor Gene Expression
$351,600John D. Ash · University Of Florida · R01 · FY2012 · EY
Core A: Administration
$351,592Frederick R Appelbaum · Fred Hutchinson Cancer Research Center · P01 · FY2020 · CA
Leveraging the TCR Repertoire to identify target neoantigens in FLT3-ITD positive Acute Myeloid Leukemia
$351,576Houda Alachkar · University Of Southern California · R01 · FY2025 · CA
Notch signaling in brain tumors
$351,575Charles George Eberhart · Johns Hopkins University · R01 · FY2011 · NS